MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Mutational effects of LRRK2 I1371V in astrocytes derived from patient specific iPSCs

    R. Banerjee, I. Datta, S. Jagtap, A. Raj (Bangalore, India)

    Objective: To identify the LRRK2 I1371V mutational effects on astroglial biology involving glutamate metabolism and glutathione machinery. Background: The underlying cause of most of the familial…
  • 2022 International Congress

    Hemichorea-hemiballismus syndrome without damage to the subthalamic nucleus?

    A. Aguiar, I. Duarte, J. Jucá Neto, G. Do Nascimento, J. Dos Santos (Fortaleza, Brazil)

    Objective: Discuss a case of Non-ketotic hyperglycemia hemiballismus hemichorea that preserves the subthalamic nucleus (STN). Background: Non-ketotic hyperglycemia hemiballismus hemichorea is a pathology characterized by…
  • 2022 International Congress

    Successful treatment of Stiff Person Syndrome with botulinum toxin

    A. Gonçalves, F. Brunet, D. Ariton, O. de Fabregues (Loures, Portugal)

    Objective: Describe a case of Stiff Person Syndrome (SPS) treated with botulinum toxin injection and alert to the utility of botulinum toxin in this disorder.…
  • 2022 International Congress

    Effect of KW-6356, a novel adenosine A2A receptor antagonist/inverse agonist, on motor and non-motor symptoms in Parkinson’s disease patients as an adjunct to levodopa therapy: Results of Phase 2b study

    T. Maeda, K. Sugiyama, K. Yamada, M. Nishi, N. Hattori (Iwate, Japan)

    Objective: To evaluate the efficacy and safety of KW-6356 in Parkinson’s disease (PD) patients with levodopa therapy, irrespective of the presence of wearing-off (WO). Background:…
  • 2022 International Congress

    Use of apomorphine infusion pump in the elderly population : a 5 years follw up study on efficacy, safety and tolerability in a cohort bases study

    C. Borrue- Fernandez, M. Mata, C. Jimeno, M. Almarcha (San Sebastian Reyes, Spain)

    Objective: Evaluate the efficacy, tolerability and safety of subcutaneous apomorphine infusion in elderly patients with advanced Parkinson's disease in a five years follow up cohort. Background: Continuous infusion by subcutaneous apomorphine pump has…
  • 2022 International Congress

    Testamentary Capacity Assessment Tool (TCAT): An update report

    P. Voskou, A. Douzenis, A. Economou, S. Papageorgiou (Athens, Greece)

    Objective: The present study reviews all studies about TCAT and its use in clinical settings, as well as its validation in different cultures. Background: TCAT…
  • 2022 International Congress

    Predictors of the change in burden and strain among caregivers of Parkinson’s disease patients

    C. Cores Bartolomé, D. Santos García, T. Fonticoba, M. Feal Painceiras, E. Suarez Castro, C. Martinez Miro, S. Jesus Maestre, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. Garcia Caldentey, N. Caballol, I. Legarda, J. Hernandez Vara, I. Cabo, L. Lopez Manzanares, I. Gonzalez Aramburu, MA. Avila Rivera, V. Gomez Mayordomo, V. Nogueira, V. Puente, J. Garcia-Soto, C. Borrue, B. Solano Vila, M. Alvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, JC. Martinez Castrillo, P. Sanchez Alonso, MG. Alonso Losada, MI. Morales Casado, I. Gaston, J. Kulisevsky, M. Blazquez Estrada, M. Seijo, J. Ruiz Martinez, C. Valero, M. Kurtis, O. de Fabregues, J. Gonzalez Ardura, R. Alonso Redondo, C. Ordas, LM. Lopez Diaz, D. Mcafee, P. Martinez Martin, P. Mir (A CORUÑA, Spain)

    Objective: The aim of the present study was to analyze the change in burden and strain after a 2-year follow-up in a cohort of caregivers…
  • 2022 International Congress

    Safety and Efficacy of unilaterally Focused Ultrasound Subthalamotomy in Early Parkinson´s Disease: The EARLY FOCUS I Study

    E. Natera-Villlaba, R. Martínez-Fernández, R. Rodríguez-Rojas, M. Del Alamo, J. Pineda-Pardo, I. Obeso, F. Hernández-Fernández, C. Gasca-Salas, M. Matarazzo, J. Obeso (Móstoles, Madrid, Spain)

    Objective: To assess the safety and efficacy of unilateral FUS subthalamotomy in early PD patients. Background: FUS subthalamotomy is feasible and therapeutically effective in Parkinson´s…
  • 2022 International Congress

    Globus pallidus as a neurosurgical target in the management of levodopa-induced dyskinesias

    A. Simonyan, V. Tyurnikov, V. Poleshuk, A. Simonyan, A. Gushcha (Moscow, Russian Federation)

    Objective: Parkinson's disease (PD) is a neurodegenerative disorder characterized by the development of motor symptoms, as well as some non-motor changes. Symptomatic treatment of PD…
  • 2022 International Congress

    Caregiver burden and quality of life in late stage Parkinson’s disease

    K. Rosqvist, A. Schrag, P. Odin (Lund, Sweden)

    Objective: To describe and assess factors associated with informal caregiver quality of life (QoL) in late stage Parkinson’s disease (PD). Background: In the late stage…
  • « Previous Page
  • 1
  • …
  • 142
  • 143
  • 144
  • 145
  • 146
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley